Gartner, Inc. (G1AR34)
B3 Stock Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 292.00 |
|---|---|
| 52-week range | 161.40 – 354.90 |
| Return, 1 month / 3 months | +21.6% / +78.0% |
| Return, 1 year / 3 years | −12.2% / −33.8% |
| Trend | Uptrend |
| RSI (14) | 89 |
| Volatility (1 year) | 67.3% |
| Worst drawdown (1 year) | -54.3% |
| Average daily value traded | 0.00M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gartner is a research and advisory company that supplies analysis, advice and benchmarks to executives and technology leaders. Its clients include information technology departments, business managers and investors who use its reports, briefings and conferences to make decisions about technology and strategy. Gartner is based in Stamford, Connecticut, in the United States, and operates around the world, serving organisations in many industries through subscription research and advisory services.
Gartner, Inc. is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code G1AR34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gartner, Inc. (G1AR34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 292.00 on 23 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 852 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.2% and over the last three months it rose 78.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 32.0% | ||
| From 52-week high | -17.7% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 78.0% | ||
| 6-month return | 60.7% | ||
| 12-month return, skipping the last month | -27.8% | ||
| Stability (higher is calmer) | 15 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 67.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -54.3% | ||
| Liquidity | 16 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M BRL | ||
| Zero-volume days | 50.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +17.6% |
|---|---|
| 1 month | +21.6% |
| 3 months | +78.0% |
| 6 months | +60.7% |
| 1 year | −12.2% |
| 3 years | −33.8% |
| 5 years | −36.4% |
Signals
| 50-day / 200-day average | 243.53 / 221.25 |
|---|---|
| Golden / death cross (60 days) | Golden, 16 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.17 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.